Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
LOADING
|||
Gross Profit Growth Accelerating
Trending higher, above historical average, strong compound growth.
Left:
||||
Year-over-year gross profit growth rate
Latest
62.11%
↑ 213% above average
Average (9y)
19.82%
Historical baseline
Range
High:80.58%
Low:-55.56%
CAGR
+13.9%
Consistent expansion
| Period | Value |
|---|---|
| 2024 | 62.11% |
| 2023 | -32.88% |
| 2022 | -20.04% |
| 2021 | 34.72% |
| 2020 | 22.22% |
| 2019 | -55.56% |
| 2018 | 80.58% |
| 2017 | 31.27% |
| 2016 | 56.42% |
| 2015 | 19.32% |